← FDA DRUG APPROVALS

FDA ANDA · ANDA211827

EFINACONAZOLE

Sponsor: TEVA PHARMS USA

APPLICATION
ANDA211827
TYPE
ANDA
ORIGINAL APPROVAL
2020-12-16
LATEST ACTION
2020-12-16
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

EFINACONAZOLEPrescription
EFINACONAZOLE 10% · SOLUTION · TOPICAL

Approval history

2020-12-16UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →